Is tilsiparatide/tilpotide safe during weight loss?

Tirzepatide/Tirzepatide is currently mainly used to treat type 2 diabetes. It has emerged in the field of weight management in recent years. As the firstGLP-1/GIP dual receptor agonist, it not only significantly promotes weight loss, but also performs well in terms of safety. It is particularly concerned by obese people and patients with type 2 diabetes. In a number of global large-scale clinical trials, Tirzepatide has shown better weight loss effects than traditional GLP-1 drugs. For example, the SURMOUNT-1 study showed that the high-dose group (15 mg) lost an average weight of 22.5%, far exceeding the placebo group and better than the control data of semaglutide.

From a safety perspective, the most common adverse reactions are mainly concentrated in the gastrointestinal tract, including nausea, vomiting, diarrhea, constipation, etc., which are usually more obvious in the initial stage, but are mostly mild, moderate, and transient, and can be alleviated by gradually increasing the dosage and eating a reasonable diet. Studies have not found that it causes severe hypoglycemia unless used in combination with insulin or sulfonylureas. More importantly, the drug has not shown any adverse effects on the cardiovascular system. On the contrary, some studies have suggested that it may have the potential benefit of improving blood lipids and lowering blood pressure, which is particularly critical for patients with obesity and metabolic syndrome.

However, caution is still required when using it in certain special populations. For example, use is not recommended in patients with severe gastrointestinal disease, or a history or family history of medullary thyroid cancer. In addition, since the safety of this drug during pregnancy and lactation has not been established, women of childbearing age should use it under the guidance of a doctor and use effective contraception.

Based on the current clinical data, tilsiparatide is a safe weight management solution when used in a standardized manner. However, patients should receive professional evaluation before use, develop a personalized treatment plan, and have regular follow-up visits to ensure a balance between efficacy and safety.

Reference materials:https://www.drugs.com/tirzepatide.html